30
Views
5
CrossRef citations to date
0
Altmetric
Review

HIV and opportunistic eye diseases

, &
Pages 173-185 | Published online: 09 Jan 2014

References

  • Sudarshan S, Biswas J. Introduction and immunopathogenesis of AIDS and anterior segment manifestation of HIV/AIDS. Indian J. Ophthalmol.56, 357–362 (2008).
  • Kestelyn PG, Cunningham ET Jr. HIV/AIDS and blindness. Bull. World Health Organ.79, 208–213 (2001).
  • Holland GN. Acquired immunodeficiency syndrome and ophthalmology: the first decade. Am. J. Ophthalmol,114, 86–95 (1992).
  • Vrabec TR. Posterior segment manifestations of HIV/AIDS. Surv. Ophthalmol.49, 131–157 (2004).
  • Goldberg DE, Smithen LM, Angelilli A, Freeman WR. HIV-associated retinopathy in the HAART era. Retina25(5), 633–649 (2005).
  • Mesarić B, Lisić M, Kniewald T, Ugrinović N, Begovac J. Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy. Lijec Vjesn.127(5–6), 123–128 (2005).
  • Jabs DA. Ocular manifestations of HIV infection. Trans. Am. Ophthalmol. Soc.93, 623–683 (1995).
  • Banker AS, Patel A. Effect of combination antiretroviral therapy on cytomegalovirus retinitis. Indian J. Opthamol.50, 29–33 (2002).
  • Holbrook JT, Jabs DA, Weinberg DV et al. Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretiroviral therapy. Arch. Ophthalmol.121, 99–107 (2003).
  • Biswas J, Madhavan HN, George AE, Kumarasamy N, Solomon S. Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center. Am. J. Ophthalmol.129(1), 9–15 (2000).
  • Biswas J, Fogla R, Gopal L et al. Current approaches to diagnosis and management of ocular lesions in human immunodeficiency virus positive patients. Indian J. Ophthalmol.50, 83–96 (2002).
  • Kuppermann BD, Petty JG, Richman DD et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am. J. Ophthalmol.115, 575–582 (1993).
  • Baldassano VF, Dunn JP, Feinberg J et al. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. N. Engl. J. Med.333, 670 (1995).
  • Cassoux N, Bodaghi B, Lautier-Frau M et al. Current status of retinal detachment in AIDS patients. J. Fr. Ophtalmol.23, 1031–1034 (2000).
  • Freeman WR, Quiceno JI, Crapotta JA, Listhaus A, Munguia D, Aguilar MF. Surgical repair of rhegmatogenous retinal detachment in immunosuppressed patients with cytomegalovirus retinitis. Ophthalmology99, 466–474 (1992).
  • Reed JB, Schwab IR, Gordon J, Morse LS. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am. J. Ophthalmol.124, 199–205 (1997).
  • MacDonald JC, Karavellas MP, Torriani FJ et al. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis. Ophthalmology107, 877–883 (2000).
  • Ormerod LD, Larkin JA, Margo CA et al. Rapidly progressive herpetic retinal necrosis: a blinding disease characteristic of advanced AIDS. Clin. Infect. Dis.26, 34–45 (1998).
  • Cano-Parra JL, Diaz-LLopis ML, Cordoba JL, Gobernado ML, Navea AL, Menezo JL. Acute iridocyclitis in a patient with AIDS diagnosed as toxoplasmosis by PCR. Ocul. Immunol. Inflamm.8, 127–130 (2000).
  • Freeman WR, Gross JG, Labelle J et al.Pneumocystis carinii choroidopathy. A new clinical entity. Arch. Ophthalmol.107, 863–867 (1989).
  • Shami MJ, Freeman W, Friedberg D et al. A multicenter study of pneumocystis choroidopathy. Am. J. Ophthalmol.112, 15–22 (1991).
  • Helm CJ, Holland GN. Ocular tuberculosis. Surv. Ophthalmol.38, 229–256 (1993).
  • Babu RB, Sudharshan S, Kumarasamy N, Therese KL, Biswas J. Ocular tuberculosis in acquired immunodeficiency syndrome. Am. J. Ophthalmol.142, 413–418 (2006).
  • Bouza E, Merino P, Muñoz P, Sanchez-Carrillo C, Yáñez J, Cortés C. Ocular tuberculosis. A prospective study in a general hospital. Medicine (Baltimore)76, 53–61 (1997).
  • Jennings A, Bilous M, Asimakis P, Maloof AJ. Mycobacterium tuberculosis presenting as chronic red eye. Cornea25, 1118–1120 (2006).
  • Singal A, Aggarwal P, Pandhi D, Rohatgi J. Cutaneous tuberculosis and phlyctenular keratoconjunctivitis: a forgotten association. Indian J. Dermatol. Venereol. Leprol.72, 290–292 (2006).
  • Dinning WJ, Marston S. Cutaneous and ocular tuberculosis: a review. J. Royal Soc. Med.78, 576–581 (1985).
  • Muccioli C, Belfort Junior R, Neves R, Rao N. Limbal and choroidal Cryptococcus infection in the acquired immunodeficiency syndrome. Am. J. Ophthalmol.120, 539–540 (1995).
  • Garelick JM, Khodabakhsh AJ, Lopez Y, Bamji M, Lister M. Scleral ulceration caused by Cryptococcus albidus in a patient with acquired immune deficiency syndrome. Cornea23, 730–731 (2004).
  • Acharya NR, Cunningham ET Jr. Corneal, anterior segment, and adnexal manifestations of human immunodeficiency virus. Int. Ophthalmol. Clin.38, 161–177 (1998).
  • McLeish WM, Pulido JS, Holland S, Culbertson WW, Winward K. The ocular manifestations of syphilis in the human immunodeficiency virus type 1-infected host. Ophthalmology97, 196–203 (1990).
  • Becerra LI, Ksiazek SM, Savino PJ et al. Syphilitic uveitis in human immunodeficiency virus-infected and non infected patients. Ophthalmology96, 1727–1730 (1989).
  • Musher DM, Hamill RJ, Baughn RE. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann. Intern. Med.113, 872–881 (1990).
  • Rosberger DF, Heinemann MH, Friedberg DN, Holland GN. Uveitis associated with human immunodeficiency virus infection. Am. J. Ophthalmol.125, 301–305 (1998).
  • Moloney G, Branley M, Kotsiou G, Rhodes D. Syphilis presenting as scleritis in an HIV-positive man undergoing immune reconstitution. Clin. Experiment. Ophthalmol.32, 526–528 (2004).
  • Moraes HV Jr. Ocular manifestations of HIV-AIDS. Curr. Opin. Ophthalmol.13, 397–403 (2002).
  • Aristimuno B, Nirankari VS, Hemady RK, Rodrigues MM. Spontaneous ulcerative keratitis in immunocompromised patients. Am. J. Ophthalmol.115, 202–208 (1993).
  • Hansen B, Kronborg G. Acanthamoeba keratitis in a non-contact lens wearer with human immunodeficiency virus. Scand. J. Infect. Dis.35, 207–209 (2003).
  • Tandon R, Vajpayee RB, Gupta V, Vajpayee M, Satpathy G, Dada T. Polymicrobial keratitis in an HIV-positive patient. Indian J. Ophthalmol.51, 87–88 (2003).
  • Friedberg DN, Stenson SM, Orenstein JM, Tierno PM, Charles NC. Microsporidial keratoconjunctivitis in acquired immunodeficiency syndrome. Arch. Ophthalmol.108, 504–508 (1990).
  • Lowder CY, McMahon JT, Meisler DM et al. Microsporidial keratoconjunctivitis caused by septata intestinalis in a patient with acquired immunodeficiency syndrome. Am. J. Ophthalmol.121, 715–717 (1996).
  • Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK; CDC; National Institutes of Health; Infectious Diseases Society of America. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm. Rep.53, 1–112 (2004).
  • Cheng L, Rao NA, Keefe KS, Avila CP Jr, Macdonald JC, Freeman WR. Cytomegalovirus iritis. Ophthalmic Surg. Lasers29, 930–932 (1998).
  • Jeng BH, Holland GN, Lowder CY, Deegan WF 3rd, Raizman MB, Meisler DM. Anterior segment and external ocular disorders associated with human immunodeficiency virus disease. Surv. Ophthalmol.52, 329–368 (2007).
  • Liesegang TJ. Varicella-zoster virus eye disease. Cornea18, 511–531 (1999).
  • Ali R, Kim JY, Henderson BA. Adnexal and anterior segment manifestations of HIV-AIDS. Int. Ophthalmol. Clin.47, 15–32 (2007).
  • Biswas J, Samanta TK, Madhavan HN, Kumarasamy N, Solomon S. Acute panuveitis with haemorrhagic hypopyon as a presenting feature of acquired immunodeficiency syndrome (AIDS). Indian J. Ophthalmol.48, 311–312 (2000).
  • Sellitti TP, Huang AJ, Schiffman J, Davis JL. Association of herpes zoster ophthalmicus with acquired immunodeficiency syndrome and acute retinal necrosis. Am. J. Ophthalmol.116, 297–301 (1993).
  • Pannell RS, Fleming DM, Cross KW. The incidence of Molluscum contagiosum, scabies and lichen planus. Epidemiol. Infect.133, 985–991 (2005).
  • Conway MD, Tong P, Olk RJ. Branch retinal artery occlusion (BRAO) combined with branch retinal vein occlusion (BRVO) and optic disc neovascularization associated with HIV and CMV retinitis. Int. Ophthalmol.19, 249–252 (1995).
  • Friedman SM, Margo CE. Bilateral central retinal vein occlusions in a patient with acquired immunodeficiency syndrome. Clinico–pathologic correlations. Arch. Ophthalmol.113, 1184–1188 (1995).
  • Park KL, Marx JL, Lopez PF, Rao NA. Noninfectious branch retinal vein occlusion in HIV-positive patients. Retina17, 162–164 (1997).
  • Mansour AM, Li HK. Frosted retinal periphlebitis in the acquired immunodeficiency syndrome. Ophthalmologica207, 182–186 (1993).
  • Corti M, Solari R, de Carolis L, Corraro R. Eye involvement in AIDS-related Kaposi sarcoma. Enferm. Infecc. Microbiol. Clin.19, 3–6 (2001).
  • Mansour AM. Neuro-ophthalmic findings in acquired immunodeficiency syndrome. J. Clin. Neuroophthalmol.10, 167–174 (1990).
  • Guech-Ongey M, Engels EA, Goedert JJ, Biggar RJ, Mbulaiteye SM. Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States. Int. J. Cancer122(11), 2590–2593 (2008).
  • Muccioli C, Belfort R, Burnier M, Rao N. Squamous cell carcinoma of the conjunctiva in a patient with the acquired immune deficiency syndrome. Am. J. Ophthalmol.121, 94–96 (1996).
  • Fogla R, Biswas J, Krishnakumar S, Madhavan HN, Kumarasamy N, Solomon S. Squamous cell carcinoma of the conjunctiva as initial presenting sign in a patient with acquired immunodeficiency syndrome (AIDS) due to human immunodeficiency virus type-2. Eye14, 246–247 (2000).
  • Porges Y, Groisman GM. Prevalence of HIV with conjunctival squamous cell neoplasia in an African provincial hospital. Cornea22, 1–4 (2003).
  • Huerva V. Topical interferon α-2b or surgical excision for primary treatment of conjunctiva-cornea intraepithelial neoplasia. Arch. Soc. Esp. Oftalmol.84(1), 5–6 (2009).
  • Holkar S, Mudhar HS, Jain A et al. Regression of invasive conjunctival squamous carcinoma in an HIV-positive patient on antiretroviral therapy. Int. J. STD AIDS16, 782–783 (2005).
  • Ormerod LD, Dailey JP. Ocular manifestations of cat-scratch disease. Curr. Opin. Ophthalmol.10, 209–216 (1999).
  • Matui R, Nussenblatt R, de Smet MD. Prevalance of tear hyposecretion and vitamin A deficiency in patients with AIDS. Invest. Ophthalmol. Vis. Sci.35, 1308 (1994).
  • Akpek EK, Haddad RS, Winkelstein JA, Gottsch JD. Bilateral consecutive central corneal perforations associated with hypogammaglobulinemia. Ophthalmology107, 123–126 (2000).
  • Raina UK, Sharma V, Jain S, Arora R, Mehta DK. Peripheral corneal thinning and silent corneal perforation in an HIV seropositive case. Acta Ophthalmol. Scand.82, 246–247 (2004).
  • Graham DA, Sires BS. Acquired trichomegaly associated with acquired immunodeficiency syndrome. Arch. Ophthalmol.115, 557–558 (1997).
  • Jabs DA, van Natta ML, Thorne JE et al. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2 (second eye involvement and retinal detachment). Ophthalmology111, 2232–22399 (2004).
  • Kuppermann BD, Holland GN. Immune recovery uveitis. Am. J. Ophthalmol.130, 103–106 (2000).
  • Kempen JH, Min YI, Freeman WR et al. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology113, 684–694 (2006).
  • Tseng AL, Walmsley SL. Rifabutin-associated uveitis. Ann. Pharmacother.29, 1149–1155 (1995).
  • Davis JL, Taskintuna I, Freeman WR, Weinberg DV, Feuer WJ, Leonard RE. Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch. Ophthalmol.115, 733–737 (1997).
  • Rathinam SR, Lalitha P. Paradoxical worsening of ocular tuberculosis in HIV patients after antiretroviral therapy. Eye21(5), 667–8 (2006).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.